Wilson Martin sold 53,389 shares of ROCKET PHARMACEUTICALS, INC. at $2.39 for −$128k on Nov 5, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
General Counsel
General Counsel
Filed Nov 9, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$127,813.27Shares × reported price
Shares traded
53,389Common Stock
Price per share
$2.39Reported price. Read footnotes for ranges.
% of reported position traded
8.92%This security and ownership context
Holdings after
545,100Direct
Trade date
Nov 5, 2026Sell
Filed
Nov 9, 2026, 4:05 PM ET4-day reporting delay
Accession
0001140361-26-042784Code S · Transaction 395777
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 598,489 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

RCKT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
RCKT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 16, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −3.9%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. F2: The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.